[HTML][HTML] Increased risk of severe clinical course of COVID-19 in carriers of HLA-C* 04: 01

…, X Wang, Z Karadeniz, J Saccomanno, JM Doehn… - …, 2021 - thelancet.com
Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic,
there has been increasing urgency to identify pathophysiological characteristics leading to …

Streptococcus pneumoniae stimulates a STING-and IFN regulatory factor 3-dependent type I IFN production in macrophages, which regulates RANTES production in …

U Koppe, K Högner, JM Doehn, HC Müller… - The Journal of …, 2012 - journals.aai.org
Streptococcus pneumoniae is the leading cause of community-acquired pneumonia. In this
study, we examine an innate immune recognition pathway that senses pneumococcal …

[HTML][HTML] CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity

JM Doehn, C Tabeling, R Biesen, J Saccomanno… - Infection, 2021 - Springer
Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Type I interferons are important in the defense of …

Streptococcus pneumoniae–Induced Oxidative Stress in Lung Epithelial Cells Depends on Pneumococcal Autolysis and Is Reversible by Resveratrol

J Zahlten, YJ Kim, JM Doehn, T Pribyl… - The Journal of …, 2015 - academic.oup.com
Background. Streptococcus pneumoniae is the most common cause of community-acquired
pneumonia worldwide. During pneumococcal pneumonia, the human airway epithelium is …

[HTML][HTML] Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19

…, X Wang, Z Karadeniz, J Saccomanno, JM Doehn… - …, 2022 - thelancet.com
Background Disease progression of subjects with coronavirus disease 2019 (COVID-19)
varies dramatically. Understanding the various types of immune response to SARS-CoV-2 is …

[HTML][HTML] Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective …

…, F Machleidt, S Albus, F Bremer, JM Doehn… - Clinical Microbiology …, 2021 - Elsevier
Objectives Dexamethasone has become the standard of care for severe coronavirus disease
2019 (COVID-19), but its virological impact is poorly understood. The objectives of this …

Role of pneumococcal autolysin for KLF4 expression and chemokine secretion in lung epithelium

…, RH Hübner, R Steinicke, JM Doehn… - American journal of …, 2015 - atsjournals.org
In severe pneumococcal pneumonia, the delicate balance between a robust inflammatory
response necessary to kill bacteria and the loss of organ function determines the outcome of …

Moraxella catarrhalis induces an immune response in the murine lung that is independent of human CEACAM5 expression and long-term smoke exposure

B Gutbier, K Fischer, JM Doehn… - … of Physiology-Lung …, 2015 - journals.physiology.org
In patients with chronic obstructive pulmonary disease (COPD), Moraxella catarrhalis
infection of the lower airways is associated with chronic colonization and inflammation during …

HLA-C* 04:01 is a Genetic Risk Allele for Severe Course of COVID-19

…, FF Marta, W Xiaomin, K Zehra, S Jacopo, D Jan-Moritz… - MedRxiv, 2020 - medrxiv.org
Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic,
there has been increasing demand to identify predictors of severe clinical course in patients …

PKCα deficiency in mice is associated with pulmonary vascular hyperresponsiveness to thromboxane A2 and increased thromboxane receptor expression

C Tabeling, E Noe, J Naujoks, JM Doehn… - Journal of Vascular …, 2016 - karger.com
Pulmonary vascular hyperresponsiveness is a main characteristic of pulmonary arterial
hypertension (PAH). In PAH patients, elevated levels of the vasoconstrictors thromboxane A2 (…